Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding.

Brown, Caitlin S; Mattson, Alicia E; Cabrera, Daniel; Coelho-Prabhu, Nayantara; Rabinstein, Alejandro A; Dettling, Theresa; McBane, Robert D; Bellolio, Fernanda

Brown, Caitlin S; Mattson, Alicia E; Cabrera, Daniel; Coelho-Prabhu, Nayantara; Rabinstein, Alejandro A; Dettling, Theresa; McBane, Robert D; Bellolio, Fernanda.

Afiliação

Brown CS; Department of Pharmacy, Mayo Clinic Rochester, MN, United States of America. Electronic address: Brown.caitlin1@mayo.edu.
Mattson AE; Department of Pharmacy, Mayo Clinic Rochester, MN, United States of America.
Cabrera D; Department of Emergency Medicine, Mayo Clinic Rochester, MN, United States of America.
Coelho-Prabhu N; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.
Rabinstein AA; Division of Neurology, Mayo Clinic, Rochester, MN, United States of America.
Dettling T; Alexion, Astra Zeneca Rare Disease, United States of America.
McBane RD; Division of Vascular Medicine, Mayo Clinic, Rochester, MN, United States of America.
Bellolio F; Department of Emergency Medicine, Mayo Clinic Rochester, MN, United States of America.

Am J Emerg Med ; 73: 1-6, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37562071

Palavras-chave

Anticoagulation; Factor Xa inhibitors; Gastrointestinal bleed; Reversal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google